PEGINTERFERON ALFA-2A [40KD] PLUS ADEFOVIR FOR 96 WEEKS IN HBEAG-NEGATIVE CHB RESULTS IN HIGH RATES OF HBSAG CLEARANCE/SEROCONVERSION

被引：1
|
作者：
Cao, Z. [1 ]
Yu, H. [1 ]
Ma, L. [1 ]
Zhang, Y. [1 ]
Liu, Y. [1 ]
Ma, B. [1 ]
Wu, H. [1 ]
Chen, X. [1 ]
机构：
[1] Beijing Youan Hosp, Beijing, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)60707-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
705
引用
收藏
页码：S283 / S283
页数：1
相关论文
共 50 条
  • [1] TREATMENT OF HBEAG-POSITIVE CHB INFECTION WITH PEGINTERFERON ALFA-2A [40KD] PLUS LAMIVUDINE OR ADEFOVIR FOR 96 WEEKS RESULTS IN HIGH RATES OF HBSAG CLEARANCE/SEROCONVERSION
    Cao, Zhenhuan
    Zhang, Yonghong
    Ma, Lina
    Jin, Yi
    Yu, Haibin
    Zhang, Xiao-dan
    Liu, Yali
    Huang, Yanxiang
    Ma, Bing
    Ren, Shan
    Wang, Lilin
    Chen, Xin-Yue
    Wei, Lai
    HEPATOLOGY, 2010, 52 (04) : 507A - 507A
  • [2] Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: On-treatment kinetics of HBsAg serum levels vary by HBV genotype
    Brunetto, Maurizia R.
    Marcellin, Patrick
    Cherubini, Beatrice
    Yurdaydin, Cihan
    Farci, Patrizia
    Hadziyannis, Stephanos J.
    Rothe, Vivien
    Regep, Loredana
    Bonino, Ferruccio
    JOURNAL OF HEPATOLOGY, 2013, 59 (06) : 1153 - 1159
  • [3] SAFETY AND TOLERABILITY OF EXTENDED (96 WEEKS) TREATMENT WITH PEGINTERFERON ALFA-2A [40KD] IN GENOTYPE D PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B
    Lampertico, Pietro
    Vigano, Mauro
    Di Costanzo, Giovan Giuseppe
    Sagnelli, Evangelista
    Fasano, Massimo
    Di Marco, Vito
    Boninsegna, Sara
    Farci, Patrizia
    Fargion, Silvia
    Giuberti, Tiziana
    Iannacone, Claudio
    Massetto, Benedetta
    Martins, Eduardo B.
    Colombo, Massimo
    HEPATOLOGY, 2010, 52 (04) : 387A - 387A
  • [4] ALT flares and sustained ALT response in patients with HBeAg-negative chronic hepatitis B treated with peginterferon alfa-2a (40KD) (PEGASYS®), peginterferon alfa-2a (40KD) plus lamivudine or lamivudine alone
    Piratvisuth, T
    Marcellin, P
    Lau, G
    Bonino, F
    Farci, P
    Hadziyannis, S
    Jin, R
    Lu, ZM
    Germanidis, G
    Yurdaydin, C
    Diago, M
    Gurel, S
    Lai, MY
    Button, P
    Why, RD
    Pluck, N
    HEPATOLOGY, 2004, 40 (04) : 656A - 657A
  • [5] Suppression of HBV DNA in patients with HBeAg-negative CHB treated with peginterferon alfa-2A (40KD) ± lamivudine:: 2-year follow-up results
    Marcellin, Patrick
    Bonino, Ferruccio
    Lau, George K.
    Farci, Patrizia
    Yurdaydin, Cihan
    Piratvisuth, Teerha
    Luo, Kangxian
    Gurel, Selim
    Hadziyannis, Stephanos
    Wang, Yuming
    Popescu, Matei
    HEPATOLOGY, 2006, 44 (04) : 550A - 550A
  • [6] HBSAG LEVELS DURING THE FIRST 24 WEEKS OF PEGINTERFERON ALFA-2A [40KD] (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B: THE PERSEAS COHORT
    Goulis, I.
    Akriviadis, E.
    Karatapanis, S.
    Deutsch, M.
    Dalekos, G.
    Raptopoulou-Gigi, M.
    Drakoulis, C.
    Bakalos, G.
    Papatheodoridis, G.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S286 - S287
  • [7] COST-EFFECTIVENESS ANALYSIS OF PEGINTERFERON ALFA-2A (40KD) IN HBEAG-NEGATIVE CHRONIC HEPATITIS B IN POLAND
    Jakubczyk, M.
    Paweska, J.
    Niewada, M.
    Berak, H.
    Szkultecka-debek, M.
    Russel-Szymczyk, M.
    VALUE IN HEALTH, 2011, 14 (07) : A277 - A277
  • [8] The cost effectiveness analysis of treatment with peginterferon alfa-2a (40KD) in patients with hbeag-negative chronic hepatitis B
    Kowalik, E.
    Niewada, M.
    Jakubczyk, M.
    Horban, A.
    Berak, H.
    Szkultecka-Debek, M.
    VALUE IN HEALTH, 2006, 9 (06) : A300 - A300
  • [9] Extended treatment with peginterferon α-2a in combination with lamivudine or adefovir for 96 weeks yields high rates of HBeAg and HBsAg seroconversion
    Cao, Zhen Huan
    Ma, Li Na
    Zhang, Hong Wei
    Liu, Ya Li
    Chen, Xin Yue
    JOURNAL OF DIGESTIVE DISEASES, 2013, 14 (08) : 446 - 450
  • [10] Response to peginterferon alfa-2a (40KD) (PEGASYS) treatment in patients with bridging fibrosis in HBeAg-positive and HBeAg-negative chronic hepatitis B
    Cooksley, Graham
    Lau, George
    Marcellin, Patrick
    Piratvisuth, Teerha
    Lai, Ming-Yang
    Bonino, Ferruccio
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A32 - A32
12345